Encompass Health (NYSE:EHC) Price Target Raised to $140.00 at Truist Financial

Key Points

• Truist Financial has raised its price target for Encompass Health (NYSE:EHC) from $135.00 to $140.00, indicating a potential upside of 17.48% from the current stock price.
• Encompass Health reported $1.40 earnings per share (EPS) for the last quarter, exceeding analysts' expectations of $1.20, alongside a revenue of $1.46 billion.
• Seven analysts currently rate the stock as a "buy," while one has issued a "strong buy" recommendation, reflecting overall positive sentiments about the stock's performance.

Encompass Health (NYSE:EHC - Free Report) had its price target increased by Truist Financial from $135.00 to $140.00 in a research note released on Thursday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also recently weighed in on EHC. Royal Bank Of Canada increased their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Barclays raised their price target on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Finally, UBS Group raised their price target on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $134.00.

Encompass Health Stock Up 1.6%

NYSE EHC traded up $1.98 during trading hours on Thursday, reaching $122.20. 169,351 shares of the company's stock were exchanged, compared to its average volume of 816,090. The company's 50-day moving average is $116.13 and its two-hundred day moving average is $109.78. Encompass Health has a one year low of $87.85 and a one year high of $123.13. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market capitalization of $12.31 billion, a price-to-earnings ratio of 23.91, a price-to-earnings-growth ratio of 2.10 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.20. The company had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business's quarterly revenue was up 12.0% on a year-over-year basis. During the same period last year, the business earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, analysts forecast that Encompass Health will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.19 dividend. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is presently 13.31%.

Hedge Funds Weigh In On Encompass Health

Several institutional investors have recently added to or reduced their stakes in EHC. OneDigital Investment Advisors LLC bought a new stake in Encompass Health during the first quarter worth $263,000. GAMMA Investing LLC grew its holdings in Encompass Health by 21.5% during the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock worth $240,000 after buying an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after buying an additional 172 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its position in Encompass Health by 30.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock worth $972,000 after purchasing an additional 2,218 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in Encompass Health by 88.7% in the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after purchasing an additional 2,017 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.